Table 2.

Effectiveness of RFA^*

Outcome	No. Patients (%)
No. of RFA sessions per pt, median (IQR)	2 (2, 3)
Complete eradication of dysplasia (CE-D) at end of treatment	43/45 (95.6)
No. of RFA sessions to CE-D, median (IQR)	2 (1, 3)
Complete eradication of intestinal metaplasia (CE-IM) at end of treatment	35/45 (77.8)
No. of RFA sessions to CE-IM, median (IQR)	3 (2, 4)
Sustained CE-D through to end of follow-up	35/43 (81.4) [7 had recurrent LGD, 1 progressed to IMC]
No. of EGDs per pt after CRD achieved, median (IQR)	4 (2, 6)

^*Total of 118 RFAs performed on 45 patients.